Overview / Abstract: |
Target Audience This activity was developed for dermatologists, dermatology advanced practice providers, and other clinicians who manage patients with moderate to severe plaque psoriasis. Program Overview Plaque psoriasis is responsible for a substantial burden on patients, their families, and the healthcare system. To address this burden, important treatment advances continue to be made, including a better understanding of the long-term safety and efficacy of approved medications, as well as the introduction of new classes of medications. Learning Objectives Upon completion of this activity, participants should be better able to: Summarize the latest research developments in the treatment of plaque psoriasis |
Expiration |
May 26, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.75 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty FACULTY_NAME |
Sponsors / Supporters / Grant Providers |
Janssen Biotech, Inc administered by Janssen Scientific Affairs, LLC and Arcutis Biotherapeutics, Inc.. |
Keywords / Search Terms |
Relias LLC Relias LLC., FreeCME., Psoriasis Free CE CME |